Agilent Technologies, Inc. (NYSE:A) is Harvey Investment Co. LLC’s 7th Largest Position

Harvey Investment Co. LLC reduced its position in Agilent Technologies, Inc. (NYSE:A) by 0.8% in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 219,282 shares of the medical research company’s stock after selling 1,845 shares during the quarter. Agilent Technologies comprises approximately 3.7% of Harvey Investment Co. LLC’s investment portfolio, making the stock its 7th largest position. Harvey Investment Co. LLC owned about 0.08% of Agilent Technologies worth $32,559,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Crewe Advisors LLC lifted its position in Agilent Technologies by 114.8% during the second quarter. Crewe Advisors LLC now owns 189 shares of the medical research company’s stock worth $25,000 after buying an additional 101 shares in the last quarter. Livelsberger Financial Advisory acquired a new position in Agilent Technologies in the third quarter valued at approximately $28,000. Ridgewood Investments LLC purchased a new position in Agilent Technologies in the second quarter worth approximately $29,000. Ashton Thomas Private Wealth LLC acquired a new stake in Agilent Technologies during the second quarter worth $39,000. Finally, Larson Financial Group LLC raised its position in Agilent Technologies by 29,300.0% in the first quarter. Larson Financial Group LLC now owns 294 shares of the medical research company’s stock valued at $43,000 after purchasing an additional 293 shares during the period. Hedge funds and other institutional investors own 87.42% of the company’s stock.

Analyst Upgrades and Downgrades

A has been the subject of a number of recent analyst reports. Stifel Nicolaus reissued a “buy” rating and set a $151.00 price objective on shares of Agilent Technologies in a research report on Monday, August 26th. Evercore ISI upped their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the stock an “in-line” rating in a report on Tuesday, October 1st. TD Cowen boosted their target price on Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a research report on Thursday, August 22nd. Citigroup upped their price target on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Finally, UBS Group lifted their price objective on shares of Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. One analyst has rated the stock with a sell rating, five have given a hold rating and nine have given a buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $144.36.

Agilent Technologies Stock Performance

Shares of A stock opened at $132.65 on Thursday. The company has a market cap of $38.70 billion, a P/E ratio of 31.45, a PEG ratio of 6.96 and a beta of 1.05. The firm has a fifty day moving average price of $140.91 and a 200 day moving average price of $138.59. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. Agilent Technologies, Inc. has a 12 month low of $96.80 and a 12 month high of $155.35.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, August 21st. The medical research company reported $1.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.06. Agilent Technologies had a return on equity of 25.26% and a net margin of 21.75%. The business had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.56 billion. During the same period in the prior year, the firm posted $1.43 EPS. The business’s quarterly revenue was down 5.6% compared to the same quarter last year. Sell-side analysts predict that Agilent Technologies, Inc. will post 5.24 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 23rd. Investors of record on Tuesday, October 1st were given a $0.236 dividend. This represents a $0.94 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date was Tuesday, October 1st. Agilent Technologies’s dividend payout ratio (DPR) is 22.22%.

Insider Buying and Selling

In related news, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total value of $1,448,550.00. Following the completion of the sale, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other news, SVP Dominique Grau sold 9,990 shares of the business’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total value of $1,448,550.00. Following the transaction, the senior vice president now owns 40,011 shares of the company’s stock, valued at approximately $5,801,595. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Padraig Mcdonnell sold 1,958 shares of the business’s stock in a transaction on Friday, July 26th. The shares were sold at an average price of $140.00, for a total transaction of $274,120.00. Following the completion of the transaction, the chief executive officer now directly owns 26,076 shares in the company, valued at $3,650,640. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 13,953 shares of company stock worth $2,013,630 in the last ninety days. 0.33% of the stock is owned by corporate insiders.

About Agilent Technologies

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.